AstraZeneca

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AstraZeneca and other ETFs, options, and stocks.

About AZN

AstraZeneca Plc is a global, science-led biopharmaceutical company focused on the discovery, development, and commercialization of prescription medicines. Its portfolio spans oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal & metabolism, and respiratory & immunology. 

CEO
Pascal Soriot
CEOPascal Soriot
Employees
96,100
Employees96,100
Headquarters
Cambridge, Cambridgeshire
HeadquartersCambridge, Cambridgeshire
Founded
1913
Founded1913
Employees
96,100
Employees96,100

AZN Key Statistics

Market cap
293.68B
Market cap293.68B
Price-Earnings ratio
26.21
Price-Earnings ratio26.21
Dividend yield
1.71%
Dividend yield1.71%
Average volume
3.50M
Average volume3.50M
High today
$190.17
High today$190.17
Low today
$187.21
Low today$187.21
Open price
$189.39
Open price$189.39
Volume
2.20M
Volume2.20M
52 Week high
$212.71
52 Week high$212.71
52 Week low
$153.41
52 Week low$153.41

Stock Snapshot

AstraZeneca(AZN) stock is priced at $188.08, giving the company a market capitalization of 293.68B. It carries a P/E multiple of 26.21 and pays a dividend yield of 1.71%.

On 2026-11-10, AstraZeneca(AZN) stock traded between a low of $187.21 and a high of $190.17. Shares are currently priced at $188.08, which is +0.5% above the low and -1.1% below the high.

AstraZeneca(AZN) shares are trading with a volume of 2.2M, against a daily average of 3.5M.

During the past year, AstraZeneca(AZN) stock moved between $153.41 at its lowest and $212.71 at its peak.

During the past year, AstraZeneca(AZN) stock moved between $153.41 at its lowest and $212.71 at its peak.

AZN News

Simply Wall St 2h
AstraZeneca EU Enhertu Approval Puts Valuation Back In Focus - Simply Wall St

...

AstraZeneca EU Enhertu Approval Puts Valuation Back In Focus - Simply Wall St
The Wall Street Journal 23h
Health Care Roundup: Market Talk

Yves Herman / Reuters The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET....

Health Care Roundup: Market Talk
TipRanks 4d
AstraZeneca Advances New Ovarian Cancer Combination Study

AstraZeneca plc (GB:AZN) announced an update on their ongoing clinical study. Study Overview: AstraZeneca’s TREVI-OC-02 study is testing torvutatug samrotecan...

Analyst ratings

91%

of 11 ratings
Buy
90.9%
Hold
0%
Sell
9.1%

More AZN News

TipRanks 4d
AstraZeneca Advances China Cancer Trial as Durvalumab Takes Center Stage

AstraZeneca plc (GB:AZN) announced an update on their ongoing clinical study. Study Overview: AstraZeneca’s Phase 3 MATTERHORN-CN study is testing treatment fo...

The Wall Street Journal 6d
AstraZeneca Made $10 Billion Offer for Rhythm Pharmaceuticals

AstraZeneca CEO Pascal Soriot Michael Nagle / Bloomberg News AstraZeneca AZN 1.92 %increase; up pointing triangle recently made a roughly $10 billion offer to...

AstraZeneca Made $10 Billion Offer for Rhythm Pharmaceuticals
TipRanks 6d
AstraZeneca Builds Hong Kong Breast Cancer Evidence in New Real-World Study

AstraZeneca plc (GB:AZN) announced an update on their ongoing clinical study. Study Overview: AstraZeneca’s official study title is Breast Cancer Real-World In...

TipRanks 7d
AstraZeneca Updates AZD4144 Drug-Interaction Study: What Investors Need to Know

AstraZeneca plc (GB:AZN) announced an update on their ongoing clinical study. Study Overview: AstraZeneca’s NCT07685600 study, officially titled “An Open-label...

TipRanks 7d
Pfizer vs. AstraZeneca: Which Pharma Stock Offers a Better Dividend?

Pfizer (PFE) and AstraZeneca (AZN) are two pharmaceutical companies that offer dividends. Both offer dividend yields above the broader market, but Pfizer offers...

People also own

Based on the portfolios of people who own AZN. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.